+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Bevacizumab Biosimilars Global Market Report 2024 - Product Thumbnail Image

Bevacizumab Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Remicade Biosimilar Global Market Report 2024 - Product Thumbnail Image

Remicade Biosimilar Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
From
Adalimumab (Humira) Biosimilars Pipeline Review - Product Thumbnail Image

Adalimumab (Humira) Biosimilars Pipeline Review

  • Report
  • November 2024
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Humira Drug Global Market Report 2024 - Product Thumbnail Image

Humira Drug Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Psoriasis Treatment - Global Strategic Business Report - Product Thumbnail Image

Psoriasis Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Adalimumab Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Adalimumab Drugs Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 140 Pages
  • Global
From
HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Loading Indicator